These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 17609620

  • 1. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
    Ekstein S, Nir A, Rein AJ, Perles Z, Bar-Oz B, Salpeter L, Algur N, Weintraub M.
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
    [Abstract] [Full Text] [Related]

  • 2. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
    Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J.
    Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
    [Abstract] [Full Text] [Related]

  • 3. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
    Horácek JM, Pudil R, Tichý M, Jebavý L, Strasová A, Praus R, Zák P, Malý J.
    Neoplasma; 2005 Dec; 52(5):430-4. PubMed ID: 16151589
    [Abstract] [Full Text] [Related]

  • 4. Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines.
    Germanakis I, Kalmanti M, Parthenakis F, Nikitovic D, Stiakaki E, Patrianakos A, Vardas PE.
    Int J Cardiol; 2006 Apr 04; 108(2):212-5. PubMed ID: 16290101
    [Abstract] [Full Text] [Related]

  • 5. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
    Mavinkurve-Groothuis AM, Groot-Loonen J, Bellersen L, Pourier MS, Feuth T, Bökkerink JP, Hoogerbrugge PM, Kapusta L.
    Pediatr Blood Cancer; 2009 May 04; 52(5):631-6. PubMed ID: 19127569
    [Abstract] [Full Text] [Related]

  • 6. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
    Horacek JM, Pudil R, Tichy M, Jebavy L, Zak P, Slovacek L, Maly J.
    Exp Oncol; 2007 Sep 04; 29(3):243-7. PubMed ID: 18004253
    [Abstract] [Full Text] [Related]

  • 7. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children.
    Aggarwal S, Pettersen MD, Bhambhani K, Gurczynski J, Thomas R, L'Ecuyer T.
    Pediatr Blood Cancer; 2007 Nov 04; 49(6):812-6. PubMed ID: 17171687
    [Abstract] [Full Text] [Related]

  • 8. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
    Pinarli FG, Oğuz A, Tunaoğlu FS, Karadeniz C, Gökçora N, Elbeg S.
    Pediatr Blood Cancer; 2005 Apr 04; 44(4):370-7. PubMed ID: 15602715
    [Abstract] [Full Text] [Related]

  • 9. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.
    Sherief LM, Kamal AG, Khalek EA, Kamal NM, Soliman AA, Esh AM.
    Hematology; 2012 May 04; 17(3):151-6. PubMed ID: 22664114
    [Abstract] [Full Text] [Related]

  • 10. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L, Thierry S, Brocas E, Van de Louw A, Pottecher J, Hours S, Moreau MH, Perrin Gachadoat D, Tenaillon A.
    Acta Anaesthesiol Scand; 2006 Mar 04; 50(3):340-7. PubMed ID: 16480468
    [Abstract] [Full Text] [Related]

  • 11. Serum NT-proBNP in the early detection of doxorubicin-induced cardiac dysfunction.
    Kittiwarawut A, Vorasettakarnkij Y, Tanasanvimon S, Manasnayakorn S, Sriuranpong V.
    Asia Pac J Clin Oncol; 2013 Jun 04; 9(2):155-61. PubMed ID: 22897825
    [Abstract] [Full Text] [Related]

  • 12. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM, Fahoum SK, Shamia MG.
    Clin Lab; 2007 Jun 04; 53(1-2):35-9. PubMed ID: 17323823
    [Abstract] [Full Text] [Related]

  • 13. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
    Kouloubinis A, Kaklamanis L, Ziras N, Sofroniadou S, Makaritsis K, Adamopoulos S, Revela I, Athanasiou A, Mavroudis D, Georgoulias V.
    Int J Cardiol; 2007 Nov 30; 122(3):195-201. PubMed ID: 17289172
    [Abstract] [Full Text] [Related]

  • 14. N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction.
    Fried I, Bar-Oz B, Perles Z, Rein AJ, Zonis Z, Nir A.
    J Pediatr; 2006 Jul 30; 149(1):28-31. PubMed ID: 16860122
    [Abstract] [Full Text] [Related]

  • 15. [Usefulness of determining the blood levels of B-type natriuretic peptide in the evaluation of cardiotoxicity in children treated with anthracyclines].
    Jackowska T, Wasilewski R.
    Med Wieku Rozwoj; 2006 Jul 30; 10(3 Pt 1):767-74. PubMed ID: 17317907
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G, Runkel S, Zdunek D, Hitzler WE.
    Clin Lab; 2005 Jul 30; 51(3-4):167-72. PubMed ID: 15819172
    [Abstract] [Full Text] [Related]

  • 17. NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors.
    Zidan A, Sherief LM, El-sheikh A, Saleh SH, Shahbah DA, Kamal NM, Sherbiny HS, Ahmad H.
    Dis Markers; 2015 Jul 30; 2015():513219. PubMed ID: 25960594
    [Abstract] [Full Text] [Related]

  • 18. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun 30; 11(6):429-32. PubMed ID: 19558803
    [Abstract] [Full Text] [Related]

  • 19. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec 30; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
    Dodos F, Halbsguth T, Erdmann E, Hoppe UC.
    Clin Res Cardiol; 2008 May 30; 97(5):318-26. PubMed ID: 18193371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.